$63.12 0.00 (%) AbbVie Inc - NYSE

Jan. 29, 2015 | 04:00 PM

Partner Headlines

  1. Earnings Scheduled For January 30, 2015

    Benzinga | Jan. 30, 2015 | 04:57AM EST
  2. Baird Remains Buyers Of Gilead Before Earnings Release

    Benzinga | Jan. 29, 2015 | 14:18PM EST
  3. Fast Money Halftime Report Final Trade From January 28

    Benzinga | Jan. 29, 2015 | 06:24AM EST
  4. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD | Jan. 28, 2015 | 13:45PM EST
  5. Gilead Sciences Still has More Upside

    GuruFocus | Jan. 22, 2015 | 15:28PM EST
  6. Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition?

    GuruFocus | Jan. 22, 2015 | 12:32PM EST
  7. Hep C price cuts a concern

    IBD | Jan. 21, 2015 | 18:42PM EST
  8. Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences

    Benzinga | Jan. 21, 2015 | 16:27PM EST
  9. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD | Jan. 21, 2015 | 12:55PM EST
  10. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD | Jan. 20, 2015 | 11:20AM EST
  11. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD | Jan. 16, 2015 | 15:43PM EST
  12. Shire Set To Acquire NPS Pharmaceuticals for $5.2 Billion

    GuruFocus | Jan. 15, 2015 | 14:29PM EST
  13. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  14. Meet 5 Top Medical Stocks Making Waves This Week

    IBD | Jan. 14, 2015 | 08:02AM EST
  15. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  16. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  17. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus | Jan. 13, 2015 | 14:55PM EST
  18. Wall Street's Wheelings And Dealings

    Benzinga | Jan. 13, 2015 | 14:49PM EST
  19. Amgen's Decline May Be Linked To Comments Of Express Script's CEO

    Benzinga | Jan. 13, 2015 | 13:18PM EST
  20. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  21. Shire Agrees To Acquire NPS Pharmaceuticals

    IBD | Jan. 12, 2015 | 14:26PM EST
  22. Shire To Acquire NPS Pharmaceuticals for $5.2 Billion

    Benzinga | Jan. 11, 2015 | 15:53PM EST
  23. CNBC's Stock Pops & Drops From January 9

    Benzinga | Jan. 10, 2015 | 12:50PM EST
  24. AbbVie

    IBD | Jan. 9, 2015 | 18:41PM EST
  25. AbbVie Stock Down After Guidance, Downgrade

    IBD | Jan. 9, 2015 | 11:49AM EST
  26. Keep an Eye on These 7 Stocks for January 9, 2015

    Benzinga | Jan. 9, 2015 | 04:09AM EST
  27. AbbVie Issues 2015 Earnings Outlook

    Benzinga | Jan. 8, 2015 | 20:04PM EST
  28. ABBVIE

    IBD | Jan. 8, 2015 | 18:44PM EST
  29. Five Stock Picks for the New Year

    FoxBusiness | Jan. 8, 2015 | 15:00PM EST
  30. Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

    Benzinga | Jan. 8, 2015 | 11:39AM EST
  31. Benzinga's Volume Movers

    Benzinga | Jan. 8, 2015 | 10:33AM EST
  32. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 8, 2015 | 10:22AM EST
  33. Morning Market Gainers

    Benzinga | Jan. 8, 2015 | 09:45AM EST
  34. Stocks Poised For Early Pop; Global Payments Gains

    IBD | Jan. 8, 2015 | 08:52AM EST
  35. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 8, 2015 | 08:12AM EST
  36. What Investors Are Looking For In NPS Pharmaceuticals Ahead Of A Potential Sale

    Benzinga | Jan. 6, 2015 | 12:34PM EST
  37. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus | Jan. 6, 2015 | 12:22PM EST
  38. Hepatitis Drugs Vie For Share

    IBD | Jan. 5, 2015 | 18:44PM EST
  39. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD | Jan. 5, 2015 | 18:21PM EST
  40. Stocks Lose More Ground; Gilead Sciences Rises

    IBD | Jan. 5, 2015 | 15:10PM EST
  41. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD | Jan. 5, 2015 | 15:09PM EST
  42. What Investors Expect From Neurocrine Biosciences' Next Drug Announcement

    Benzinga | Jan. 2, 2015 | 14:53PM EST
  43. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  44. U.S. M&A Seen Staying Robust In 2015, Fueled By Oil

    IBD | Dec. 29, 2014 | 18:38PM EST
  45. Gilead Sciences Seen Benefiting From Hep C Market

    IBD | Dec. 29, 2014 | 15:34PM EST
  46. Is it Time to Sell Gilead Sciences?

    GuruFocus | Dec. 29, 2014 | 15:05PM EST
  47. Stocks Hold Near Highs; LifeLock Breaks Out

    IBD | Dec. 29, 2014 | 11:59AM EST
  48. Facebook Among IBD 50's Top 5 Earnings Kings In 2014

    IBD | Dec. 27, 2014 | 08:02AM EST
  49. IBD 50: Biotechs Hammered, Then Find Support

    IBD | Dec. 26, 2014 | 18:27PM EST
  50. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
Trading Center